Eggermont, Alexander MM ;
Meshcheryakov, Andrey ;
Atkinson, Victoria...
Eggermont , A MM , Meshcheryakov , A , Atkinson , V , Blank , C U , Mandala , M , Long , G V , Barrow , C , Di Giacomo , A M , Fisher , R , Sandhu , S , Kudchadkar , R , Ortiz Romero , P L , Svane , I M , Larkin , J , Puig , S , Hersey , P , Quaglino , P , Queirolo , P , Stroyakovskiy , D , Bastholt , L , Mohr , P , Hernberg , M , Chiarion-Sileni , V , Strother , M , Hauschild , A , Yamazaki , N , van Akkooi , A CJ , Lorigan , P , Krepler , C , Ibrahim , N , Marreaud , S , Kicinski , M , Suciu , S & Robert , C 2021 , ' Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma ' , European Journal of Cancer , vol. 158 , pp. 156-168 . https://doi.org/10.1016/j.ejca.2021.09.023.
,
2021
